Soluble Thrombomodulin
BRD ID: 2041
Tier: SOP
Source: TCP Project
Document: BARC PRO 025 Souble Thrombomodulin Removed Hidden Fields Size Reduced.pdf[Size: 775.59 KB]
Number of times downloaded: 711
Description
This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical
Center (BMC) to quantify levels of soluble thrombomodulin (sTM) in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).
Biospecimens
FluidPlasma
Diagnoses
NeoplasticCarcinoma
Normal
Topics
Biospecimen Aliquots and Components
Platform-specific Methodology